# Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan

> **NCT00543244** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Pegylated interferon alfa and ribavirin

## Key facts

- **NCT ID:** NCT00543244
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-01
- **Primary completion:** 2008-10
- **Final completion:** 2008-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2008-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00543244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00543244, "Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00543244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*